Literature DB >> 20663976

Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging.

Natsuko Tsuda1, Osamu Matsui.   

Abstract

PURPOSE: To analyze the difference in signal intensity on gadoxetic acid-enhanced magnetic resonance (MR) images between normal and cirrhotic livers in rats as correlated with the expressions of the transporters of gadoxetic acid and the morphopathologic change in bile canaliculi.
MATERIALS AND METHODS: Institutional animal review board approval was received prior to the commencement of all studies. Fifteen rats received thioacetamide (TAA) in their drinking water for 12 weeks to induce liver cirrhosis. As a control, 15 rats were given normal water. After 12 weeks, seven rats in the TAA group and seven rats in the control group underwent gadoxetic acid-enhanced MR imaging (0.025 mmol gadolinium per kilogram of body weight). Five rats in each group were used for comparison of transporter (organic anion-transporting polypeptide 1 [oatp1] and multidrug resistance-associated protein 2 [mrp2]) activities. Three rats in each group were used for morphologic examination. The Wilcoxon rank sum test was used for statistical analysis.
RESULTS: Signal enhancement of the liver in the TAA group significantly decreased in comparison with that in the control group, although the signal enhancement of the kidney in both groups was almost identical. The oatp1 and mrp2 activities were as follows: 2.17 +/- 0.71 (standard deviation) for oatp1 in the TAA group, 2.58 +/- 0.35 for oatp1 in the control group, 3.37 +/- 1.04 for mrp2 in the TAA group, and 0.93 +/- 0.34 for mrp2 in the control group (P = .175 for oatp1, P = .009 for mrp2). At morphologic examination, enlargement of bile canaliculi and hyperplasia or elongation of microvilli were observed in the TAA group.
CONCLUSION: Findings showed that liver cirrhosis promotes the elimination of gadoxetic acid mediated by mrp2; therefore, mrp2 up-regulation may explain the significant signal intensity loss noted on gadoxetic acid-enhanced MR images in the rat. In addition, the up-regulation of mrp2 may be accompanied by morphologic changes in bile canaliculi and microvilli. (c) RSNA, 2010.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663976     DOI: 10.1148/radiol.10092065

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  38 in total

1.  Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression.

Authors:  Natsuko Tsuda; Osamu Matsui
Journal:  Eur Radiol       Date:  2011-08-11       Impact factor: 5.315

Review 2.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

Review 3.  Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review.

Authors:  Paola Erra; Marta Puglia; Alfonso Ragozzino; Simone Maurea; Raffaele Liuzzi; Giuseppe Sabino; Luigi Barbuto; Alberto Cuocolo; Massimo Imbriaco
Journal:  Radiol Med       Date:  2015-04-22       Impact factor: 3.469

4.  The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach.

Authors:  Diana Feier; Csilla Balassy; Nina Bastati; Romana Fragner; Friedrich Wrba; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

5.  Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.

Authors:  N Verloh; M Haimerl; F Zeman; M Schlabeck; A Barreiros; M Loss; A G Schreyer; C Stroszczynski; C Fellner; P Wiggermann
Journal:  Eur Radiol       Date:  2014-02-16       Impact factor: 5.315

6.  Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.

Authors:  Bang-Bin Chen; Chao-Yu Hsu; Chih-Wei Yu; Shwu-Yuan Wei; Jia-Horng Kao; Hsuan-Shu Lee; Tiffany Ting-Fang Shih
Journal:  Eur Radiol       Date:  2011-08-31       Impact factor: 5.315

7.  Dynamic Contrast-Enhanced MRI of OATP Dysfunction in Diabetes.

Authors:  Dorela D Shuboni-Mulligan; Maciej Parys; Barbara Blanco-Fernandez; Christiane L Mallett; Regina Schnegelberger; Marilia Takada; Shatadru Chakravarty; Bruno Hagenbuch; Erik M Shapiro
Journal:  Diabetes       Date:  2018-11-28       Impact factor: 9.461

8.  Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).

Authors:  Bang-Bin Chen; Takamichi Murakami; Tiffany Ting-Fang Shih; Michiie Sakamoto; Osamu Matsui; Byung-Ihn Choi; Myeong-Jin Kim; Jeong Min Lee; Ren-Jie Yang; Meng-Su Zeng; Ran-Chou Chen; Ja-Der Liang
Journal:  Liver Cancer       Date:  2015-10-15       Impact factor: 11.740

9.  Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI.

Authors:  Simon Matoori; Johannes M Froehlich; Stefan Breitenstein; Aleksis Doert; Viktoria Pozdniakova; Dow-Mu Koh; Andreas Gutzeit
Journal:  Eur Radiol       Date:  2015-09-03       Impact factor: 5.315

10.  Effect of lapatinib on hepatic parenchymal enhancement on gadoxetate disodium (EOB)-enhanced MRI scans of the rat liver.

Authors:  Yuko Nakamura; Yutaka Hirokawa; Shigemi Kitamura; Wataru Yamasaki; Koji Arihiro; Fuminari Tatsugami; Makoto Iida; Hideaki Kakizawa; Shuji Date; Kazuo Awai
Journal:  Jpn J Radiol       Date:  2013-04-19       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.